Crestline Management, LP Balchem Corp Transaction History

Crestline Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$73.39 - $110.81 $810,665 - $1.22 Million	-11,046 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$97.22 - $116.69 $1.07 Million - $1.29 Million	11,046 New	11,046 $1.24 Million
Q2 2018 Aug 14, 2018	SELL	$80.7 - $100.4 $2.16 Million - $2.69 Million	-26,806 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$70.84 - $82.37 $553,827 - $643,968	7,818 Added 41.17%	26,806 $2.19 Million
Q4 2017 Feb 14, 2018	BUY	$79.39 - $87.71 $1.51 Million - $1.67 Million	18,988 New	18,988 $1.53 Million
Q3 2017 Nov 14, 2017	SELL	$73.12 - $81.91 $406,327 - $455,173	-5,557 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	5,557	5,557 $432,000

374

28.2M

267K

5.7K

Ticker BCPC
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 32,120,600
Market Cap $5.11B
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.